We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Industry Anxiously Awaiting Combination Product Guidances
Industry Anxiously Awaiting Combination Product Guidances
October 28, 2005
Upcoming FDA guidance is necessary to accelerate approvals of combination products because of lingering uncertainties about whether manufacturers must meet drug or device requirements, industry officials and consultants say.